{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T13:46:30Z","timestamp":1742391990544},"reference-count":41,"publisher":"Oceanside Publications Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2022,3,1]]},"DOI":"10.2500\/aap.2022.43.220008","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T10:47:26Z","timestamp":1648032446000},"page":"93-95","source":"Crossref","is-referenced-by-count":5,"title":["Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist\/immunologist"],"prefix":"10.2500","volume":"43","author":[{"given":"Joseph A.","family":"Bellanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell A.","family":"Settipane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJMp2109285","article-title":"Confronting our next national health disaster - long-haul COVID","volume":"385","author":"Phillips","year":"2021","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2500\/aap.2022.43.210107","article-title":"Treatment strategies for postviral olfactory dysfunction: a systematic review","volume":"43","author":"Helman","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2500\/aap.2022.43.210116","article-title":"Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19","volume":"43","author":"Tuzer","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2500\/aap.2022.43.210097","article-title":"Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber","volume":"43","author":"Ramirez","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2500\/aap.2022.43.210123","article-title":"Profiles of sensitization and comorbidity in asthma patients with markedly increased serum total IgE (>1000 kU\/L)","volume":"43","author":"Wu","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2500\/aap.2022.43.210001","article-title":"Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children","volume":"43","author":"Kim","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2500\/aap.2022.43.210003","article-title":"Impact of socioeconomic factors and house cleaning on asthma control in women","volume":"43","author":"Ozden Sertcelik","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B8","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.2500\/aap.2020.41.200062","article-title":"Hereditary angioedema: differential diagnosis, diagnostic tests, and family screening","volume":"41","author":"Manning","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B9","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.2500\/aap.2020.41.200065","article-title":"Clinical presentation of hereditary angioedema","volume":"41","author":"Azmy","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B10","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2500\/aap.2020.41.200081","article-title":"Hereditary angioedema: pathophysiology (HAE type I, HAE type II, and HAE nC1-INH)","volume":"41","author":"Wedner","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B11","doi-asserted-by":"crossref","first-page":"S08","DOI":"10.2500\/aap.2020.41.200050","article-title":"Hereditary angioedema: epidemiology and burden of disease","volume":"41","author":"Lumry","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B12","doi-asserted-by":"crossref","first-page":"S03","DOI":"10.2500\/aap.2020.41.200040","article-title":"Definition and classification of hereditary angioedema","volume":"41","author":"Proper","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2500\/aap.2020.41.200011","article-title":"Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States","volume":"41","author":"Tachdjian","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2500\/aap.2020.41.190005","article-title":"Long-term safety outcomes of prekallikrein (Fletcher factor) deficiency: a systematic literature review of case reports","volume":"41","author":"Girolami","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2500\/aap.2020.41.190021","article-title":"Manufacturing of plasma-derived C1-inhibitor concentrate for treatment of patients with hereditary angioedema","volume":"41","author":"Simon","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2500\/aap.2021.42.200073","article-title":"Psychology and hereditary angioedema: a systematic review","volume":"42","author":"Savarese","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2500\/aap.2021.42.200106","article-title":"Androgen use in hereditary angioedema: a critical appraisal and approaches to transitioning from androgens to other therapies","volume":"42","author":"Johnston","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B18","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.2500\/aap.2020.41.200057","article-title":"Hereditary angioedema and shared decision making","volume":"41","author":"Settipane","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B19","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.2500\/aap.2020.41.200056","article-title":"Hereditary angioedema: investigational therapies and future research","volume":"41","author":"Kaplan","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B20","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.2500\/aap.2020.41.200077","article-title":"Hereditary angioedema: special considerations in women","volume":"41","author":"Yakaboski","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B21","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2500\/aap.2020.41.200042","article-title":"Hereditary angioedema: special considerations in children","volume":"41","author":"Johnston","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B22","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.2500\/aap.2020.41.200059","article-title":"Hereditary angioedema: comprehensive management plans and patient support","volume":"41","author":"Paige","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B23","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.2500\/aap.2020.41.200092","article-title":"Hereditary angioedema: long-term prophylactic treatment","volume":"41","author":"Li","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B24","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.2500\/aap.2020.41.200058","article-title":"Triggers and short-term prophylaxis in patients with hereditary angioedema","volume":"41","author":"Craig","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B25","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.2500\/aap.2020.41.200066","article-title":"Hereditary angioedema: on-demand treatment of angioedema attacks","volume":"41","author":"Christiansen","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2500\/aap.2021.42.210066","article-title":"Effect of COVID-19 on hereditary angioedema activity and quality of life","volume":"42","author":"Can Bostan","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2500\/aap.2021.42.210019","article-title":"Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema","volume":"42","author":"Ocak","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2500\/aap.2021.42.210015","article-title":"Etiology and predictors of cluster attacks of hereditary angioedema that recur despite pharmaceutical treatment","volume":"42","author":"Johnson","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2500\/aap.2021.42.210034","article-title":"Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: review of phase II and III studies","volume":"42","author":"Manning","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2500\/aap.2021.42.210006","article-title":"Short-term prophylaxis for children and adolescents with hereditary angioedema","volume":"42","author":"Ajewole","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B31","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2500\/aap.2021.42.210017","article-title":"Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs","volume":"42","author":"Riedl","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B32","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2500\/aap.2021.42.210029","article-title":"Caregivers' role in managing hereditary angioedema and perceptions of treatment-related burden","volume":"42","author":"Craig","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B33","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2500\/aap.2021.42.210025","article-title":"Patient perspectives on the treatment burden of injectable medication for hereditary angioedema","volume":"42","author":"Radojicic","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2500\/aap.2021.42.210001","article-title":"Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema","volume":"42","author":"Cao","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2500\/aap.2021.42.200127","article-title":"Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema","volume":"42","author":"Castaldo","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2500\/aap.2022.43.210086","article-title":"Guidelines for management of hereditary angioedema: What is new? What is missing?","volume":"43","author":"Radojicic","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B37","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2500\/aap.2022.43.210099","article-title":"Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management","volume":"43","author":"Grivcheva-Panovska","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2500\/aap.2022.43.220005","article-title":"Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema","volume":"43","author":"Chepy","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2500\/aap.2022.43.210104","article-title":"How satisfactory is on-demand icatibant from the patients' perspective in real life?","volume":"43","author":"Beyaz","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2500\/aap.2022.43.210002","article-title":"Female sex as a risk factor for penicillin drug allergy in the inpatient setting","volume":"43","author":"Voelker","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2500\/aap.2022.43.210115","article-title":"Cost assessment of allergy procedures to improve high-value care implementation","volume":"43","author":"Diehl","year":"2022","journal-title":"Allergy Asthma Proc"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2022\/00000043\/00000002\/art00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T10:42:03Z","timestamp":1658140923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2022.43.220008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3,1]]}},"alternative-id":["1088-5412(20220301)43:2L.93;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2022.43.220008","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}